Pleural Plaques

Pleural plaques are the most common manifestation of asbestos exposure, consisting of well-defined areas of fibrous thickening or calcification on the parietal pleura — the membrane lining the inside of the chest wall. They are found in more than 50% of individuals with significant occupational asbestos exposure and serve as a reliable radiographic marker of prior asbestos inhalation.¹

It is important to understand that pleural plaques are benign. They are not cancerous and are not considered a precancerous condition. The presence of pleural plaques does not, in itself, increase the risk of developing mesothelioma or lung cancer beyond the risk already conferred by the underlying asbestos exposure. However, because pleural plaques confirm that asbestos exposure has occurred, their presence should prompt awareness of the other serious conditions that asbestos can cause.²

Pleural plaques typically develop 20 to 30 years after initial asbestos exposure and are usually discovered incidentally on chest imaging obtained for other reasons. They appear as localized areas of pleural thickening, often bilateral, and are most commonly found on the posterolateral chest wall, diaphragm, and mediastinal pleura. Over time, they may become calcified, appearing as bright white areas on chest X-ray or CT scan.³

In the vast majority of cases, pleural plaques do not cause symptoms and do not require treatment. However, their identification is clinically significant because it confirms a history of asbestos exposure and should prompt ongoing medical surveillance for more serious asbestos-related diseases, including asbestosis, mesothelioma, and asbestos-related lung cancer.

Pleural plaques are classified based on their composition and appearance:

• Hyaline (non-calcified) plaques — composed of acellular collagen fibers arranged in a basket-weave pattern; appear as areas of pleural thickening on CT scan; more common than calcified plaques
• Calcified plaques — plaques that have undergone calcium deposition over time; appear as dense, bright white areas on imaging; calcification generally increases with time since exposure

Pleural plaques must be distinguished from diffuse pleural thickening, which is a separate asbestos-related condition involving widespread thickening of the visceral pleura that can restrict lung function.

Pleural plaques are generally asymptomatic. When symptoms are reported in patients with pleural plaques, they are most often attributable to coexisting conditions rather than the plaques themselves:

• Most patients have no symptoms
• Mild chest tightness (uncommon and typically not clinically significant)
• Mild restriction of lung function may be detected on pulmonary function testing in cases with extensive bilateral plaques, though this is debated
• Anxiety related to the diagnosis and its implications regarding asbestos exposure

If a patient with pleural plaques develops significant respiratory symptoms — such as worsening shortness of breath, chest pain, or persistent cough — further evaluation should be pursued to rule out other asbestos-related conditions including diffuse pleural thickening, asbestosis, or malignancy.

Pleural plaques are caused by inhalation of asbestos fibers. The fibers travel through the airways, penetrate the lung tissue, and reach the pleural space, where they trigger a localized inflammatory and fibrotic response in the parietal pleura.

• Occupational asbestos exposure — the most common cause, affecting workers in construction, shipbuilding, insulation, mining, manufacturing, and automotive industries
• Environmental asbestos exposure — residents of areas with naturally occurring asbestos or near asbestos processing facilities
• Secondary exposure — family members of asbestos workers may develop plaques from take-home fiber exposure

The latency period between initial asbestos exposure and the development of detectable pleural plaques is typically 20 to 30 years. Plaques develop in a dose-response relationship — higher exposure levels and longer durations of exposure are associated with more extensive plaque formation.¹

• Occupational asbestos exposure — the primary risk factor; prevalence increases with cumulative exposure
• Time since first exposure — plaques are more common and more likely to be calcified with increasing time since initial exposure
• Duration of exposure — longer exposure periods increase the likelihood of plaque development
• Type of asbestos — all fiber types can cause plaques, including chrysotile, crocidolite, amosite, and tremolite
• Environmental exposure — living in areas with naturally occurring asbestos (e.g., parts of Turkey, Greece, Corsica, and certain areas of the United States)

Pleural plaques are typically discovered incidentally on imaging studies:

• Chest X-ray — calcified plaques appear as well-defined, dense white areas along the chest wall or diaphragm; non-calcified plaques may be difficult to detect on plain radiographs
• CT scan — the most sensitive imaging modality for detecting pleural plaques; reveals both calcified and non-calcified plaques with precise localization; high-resolution CT (HRCT) is preferred
• Pulmonary function testing — may show mild restrictive changes in patients with extensive plaques, though findings are often normal
• Clinical history — documentation of asbestos exposure history supports the diagnosis

Pleural plaques must be distinguished from:

• Diffuse pleural thickening (more extensive, involves visceral pleura, causes greater functional impairment)
• Pleural mesothelioma (irregular, nodular pleural thickening with effusion)
• Pleural metastases from other cancers
• Post-inflammatory pleural changes (from prior infection, trauma, or surgery)

Pleural plaques are benign and generally require no treatment:

• No specific treatment — plaques themselves do not require medical or surgical intervention
• Ongoing surveillance — regular chest imaging (typically low-dose CT) is recommended to monitor for the development of more serious asbestos-related conditions
• Smoking cessation — strongly recommended for individuals with asbestos exposure, as smoking combined with asbestos exposure dramatically increases lung cancer risk (multiplicative effect)
• Symptom management — if coexisting conditions cause respiratory symptoms, they should be evaluated and treated independently
• Medical surveillance programs — individuals with pleural plaques should be enrolled in ongoing monitoring programs, which may include periodic chest imaging and pulmonary function testing

The most important clinical action when pleural plaques are identified is to confirm the patient's asbestos exposure history and ensure they receive appropriate long-term surveillance for mesothelioma, lung cancer, and asbestosis.

The prognosis for pleural plaques themselves is excellent:

• Pleural plaques are benign and do not transform into cancer
• They do not significantly impact life expectancy when present in isolation
• Most patients with pleural plaques maintain normal or near-normal lung function
• The presence of plaques does not independently increase the risk of mesothelioma or lung cancer beyond the risk conferred by the underlying asbestos exposure

However, because pleural plaques confirm asbestos exposure, affected individuals should remain vigilant. The same asbestos exposure that caused the plaques can also, independently, lead to the development of mesothelioma, asbestos-related lung cancer, or asbestosis — conditions that carry significantly more serious prognoses.²

Prevention of pleural plaques requires preventing asbestos exposure:

• Strict compliance with OSHA permissible exposure limits for asbestos
• Use of appropriate respiratory protection in occupations with potential asbestos exposure
• Professional asbestos surveys and abatement in buildings constructed before 1980
• Avoiding disturbance of asbestos-containing materials during home renovation
• Environmental monitoring in communities near natural asbestos deposits

Receiving a diagnosis of pleural plaques can be anxiety-provoking, even though the condition itself is benign. Important considerations include:

• Understanding the diagnosis — pleural plaques are not cancer and do not become cancer. They are a marker of asbestos exposure, not a disease that requires treatment
• Commit to surveillance — follow your physician's recommendations for periodic imaging and check-ups
• Stop smoking — if you smoke, quitting is one of the most important steps you can take. The combination of asbestos exposure and smoking increases lung cancer risk by up to 50-fold compared to nonsmokers without asbestos exposure
• Document your exposure — maintain detailed records of when, where, and how asbestos exposure occurred; this information is important for medical monitoring and any future legal claims
• Know the warning signs — seek immediate medical attention for new or worsening shortness of breath, persistent chest pain, unexplained weight loss, or persistent cough, as these could indicate a more serious asbestos-related condition